TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Fortrea Holdings Inc. (FTRE)

Healthcare Biotechnology
18.90 $
-1.2% vs. previous close
Closing price · As of: 3. Aug 2026

Fortrea Holdings Inc. (FTRE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -17 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Cash Flow FTRE
Tick rows to compare them in a chart (up to 4) Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
1.9 12 -26 274 -2.4 17 -124 22 87 129 -17 -17 182
25 24 24 21 21 21 20 20 20 19 20 20 78
11 16 15 15 13 15 15 23 22 15 11 13 61
-37 35 8.7 351 -29 34 -89 10 60 133 -18 -28 148
5.1 9.4 9.3 11 8.2 3.2 2.9 7.5 7.3 7.5 8.0 9.0 32
2.7 -9.0 -9.2 265 -8.1 3.5 16 -7.5 13 -7.5 -8.0 -7.0 -9.2
0.0 0.0 89 -39 -50 -76 0.0 0.0 -126
-7.7 -4.6 21 -504 -14 -1.1 88 -39 -50 -76 0.0 0.0 -126
-5.1 1.1 -16 33 -21 13 -17 -20 50 43 -27 -24 42
-3.2 3.0 -35 263 -11 20 -127 14 80 122 -25 -26 151

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?